An essential tool for detection of respiratory illnesses

By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.

Photo: An essential tool for detection of respiratory illnesses

Seegene invents its new Seeplex 18-plex Respiratory Test as an essential tool for active surveillance and treatment of respiratory illnesses. Compared to the usual ‘single pathogen – single test’ testing regime the new multiplex-formatted diagnostic test, for which nasopharyngeal spirates, nasopharyngeal swabs or bronchoalveolar lavage samples could be used, is cost-effective and delivers fast results.

The Test detects the following  RNA viruses, DNA viruses and pneumonia bacteria:

      -          Influenza A virus
-          Influenza B virus
-          Human respiratory syncytial virus A
-          Human respiratory syncytial cirus B
-          Human parainfluenzae virus 1
-          Human parainfluenzae virus 2
-          Human parainfluenzae virus 3
-          Human coronavirus 229E/NL63
-          Human coronavirus OC43/HKU1
-          Human rhinovirus
-          Human enterovirus
-          Human adenovirus
-          Human bocavirus
-          Legionella pneumoniae
-          Streptococcus pneumoniae
-          Chlamydophila pneumoniae
-          Haemophilus influenzae
-          Mycoplasma pneumoniae

14.09.2007

More on the subject:

Related articles

Photo

News • HPV oncoprotein quantification

Urine test improves cervical cancer early detection

A new test shows promise in making cervical cancer screening more accessible and less invasive by detecting oncoproteins of the human papillomavirus (HPV) in urine samples.

Photo

News • Circulating tumor extracellular vesicles

Metastatic prostate cancer: better monitoring with new liquid biopsy method

A new study shows that extracellular vesicles shed by prostate cancer cells contain tumor-derived material that can be used as biomarkers of therapy response and resistance in metastatic disease.

Photo

News • Combined ESR and CBC/DIFF

Horiba launches new compact hematology analyzers

Analytical and measurement technology specialist Horiba has expanded its compact hematology instrument range with the launch of new models with Erythrocyte Sedimentation Rate (ESR) on board.

Related products

Subscribe to Newsletter